ARCALYST Trademark

Trademark Overview

On Thursday, June 22, 2006, a trademark application was filed for ARCALYST with the United States Patent and Trademark Office. The USPTO has given the ARCALYST trademark a serial number of 78914043. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 22, 2010. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The ARCALYST trademark is filed in the Pharmaceutical Products category with the following description:

Injectable pharmaceutical preparations and substances for the treatment of immunological diseases and disorders, heart and circulatory diseases, hypertension, cardiovascular diseases, urological diseases, gastrointestinal disorders, metabolic diseases, chronic peripheral arterial occlusive diseases
arcalyst

General Information

Serial Number78914043
Word MarkARCALYST
Filing DateThursday, June 22, 2006
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 22, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2007

Trademark Statements

Goods and ServicesInjectable pharmaceutical preparations and substances for the treatment of immunological diseases and disorders, heart and circulatory diseases, hypertension, cardiovascular diseases, urological diseases, gastrointestinal disorders, metabolic diseases, chronic peripheral arterial occlusive diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 28, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Monday, November 22, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 22, 2010ABANDONMENT - NO USE STATEMENT FILED
Wednesday, April 7, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 6, 2010EXTENSION 5 GRANTED
Thursday, April 1, 2010EXTENSION 5 FILED
Thursday, April 1, 2010TEAS EXTENSION RECEIVED
Tuesday, September 29, 2009EXTENSION 4 GRANTED
Wednesday, September 23, 2009EXTENSION 4 FILED
Wednesday, September 23, 2009TEAS EXTENSION RECEIVED
Monday, March 30, 2009EXTENSION 3 GRANTED
Tuesday, March 10, 2009EXTENSION 3 FILED
Monday, March 30, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 10, 2009TEAS EXTENSION RECEIVED
Friday, August 29, 2008EXTENSION 2 GRANTED
Friday, August 29, 2008EXTENSION 2 FILED
Friday, August 29, 2008TEAS EXTENSION RECEIVED
Friday, May 9, 2008DIVISIONAL PROCESSING COMPLETE
Monday, April 21, 2008DIVISIONAL REQUEST RECEIVED
Monday, April 21, 2008PAPER RECEIVED
Thursday, April 17, 2008EXTENSION 1 GRANTED
Thursday, April 17, 2008EXTENSION 1 FILED
Thursday, April 17, 2008TEAS EXTENSION RECEIVED
Tuesday, October 23, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 27, 2007CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Wednesday, September 26, 2007ASSIGNED TO PETITION STAFF
Friday, September 14, 2007FAX RECEIVED
Saturday, September 8, 2007EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, March 19, 2007EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 20, 2007PUBLISHED FOR OPPOSITION
Wednesday, January 31, 2007NOTICE OF PUBLICATION
Friday, December 29, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 29, 2006ASSIGNED TO LIE
Monday, December 11, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 7, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 6, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 6, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 27, 2006NON-FINAL ACTION E-MAILED
Monday, November 27, 2006NON-FINAL ACTION WRITTEN
Monday, November 27, 2006ASSIGNED TO EXAMINER
Wednesday, June 28, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

arcalyst diseases disorders gastrointestinal urological metabolic chronic occlusive arterial peripheral cardiovascular